Skip to main content
. 2021 Jun 16;8:681669. doi: 10.3389/fmolb.2021.681669

TABLE 1.

Characteristics of patients undergoing UT-VATS or TBLC.

UT-VATS (n = 67) TBLC (n = 70) p value
Age b 54.0 (20–70) 50.0 (21–72) 0.27
Male/female, n 39/28 28/42 0.04
Smoking history, no/yes, n 28/39 16/54 0.03
FVC% a 81.3 (2.7) 71.8 (2.8) 0.01
FEV1% a 80.7 (2.6) 73.0 (2.8) 0.05
DLCO% a 68.7 (2.4) 47.2 (2.5) <0.001
Biopsy location, n
 LUL 10 NA
 LL(lingular)L 42 NA
 LL(lower)L 53 44
 RUL 1 4
 RML 9 NA
 RLL 8 295
Sample number, n
 1 14 (20.9) 1 (1.4)
 2 50 (74.6) 1 (1.4)
 3 3 (4.5) 8 (11.4)
 4 9 (12.9)
 5 31 (44.3)
 >5 20 (28.6)
 Sample number b 2 (1–3) 5 (1–8)
 Sample size b , cm2/mm2 5.3 (1–32.0) c 9.0 (1–40.0)d

Values are presented as

a

mean (SEM)

b

median (interquartile range) where appropriate.

c

: cm2

d

: mm2

UT-VATS: uniportal and tubeless-video-assisted thoracic surgery, TBLC: transbronchial lung cryobiopsy, FVC: forced vital capacity, FEV1: forced expiratory volume in 1 s, DLCO: carbon-monoxide diffusion coefficient. LUL: left upper lobe, RUL: right upper lobe, RML: right middle lobe, RLL: right lower lobe.